Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    St075182

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 24729-96-2, St075182, Dtxsid80860321, Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-o-phosphono-1-thiooctopyranoside, Akos015960484, Ncgc00389304-01
    Molecular Formula
    C18H34ClN2O8PS
    Molecular Weight
    505.0  g/mol
    InChI Key
    UFUVLHLTWXBHGZ-UHFFFAOYSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate
    2.1.2 InChI
    InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)
    2.1.3 InChI Key
    UFUVLHLTWXBHGZ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 24729-96-2

    2. St075182

    3. Dtxsid80860321

    4. Methyl 7-chloro-6,7,8-trideoxy-6-[(1-methyl-4-propylprolyl)amino]-2-o-phosphono-1-thiooctopyranoside

    5. Akos015960484

    6. Ncgc00389304-01

    7. Ac-11380

    8. Methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside2-(dihydrogenphosphate)

    9. Db-046536

    10. Ft-0603210

    2.3 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 505.0 g/mol
    Molecular Formula C18H34ClN2O8PS
    XLogP3-1.2
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count9
    Exact Mass504.1462019 g/mol
    Monoisotopic Mass504.1462019 g/mol
    Topological Polar Surface Area174 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity658
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count9
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 21  
    Drug NameCLEOCIN
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050680); PHARMACIA AND UPJOHN (Application Number: N050767. Patent: 6495157)

    2 of 21  
    Drug NameCLINDA-DERM
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPADDOCK LLC (Application Number: A063329)

    3 of 21  
    Drug NameCLINDAGEL
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPRECISION DERMAT (Application Number: N050782. Patent: 6387383)

    4 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyBAXTER HLTHCARE CORP (Application Number: N208083)

    5 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
    Active IngredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    CompanyACTAVIS LABS UT INC (Application Number: A205128); MYLAN PHARMS INC (Application Number: A065443); PERRIGO ISRAEL (Application Number: A090979); PERRIGO ISRAEL (Application Number: A202440); TARO (Application Number: A206218); TOLMAR (Application Number: A203688); TOLMAR (Application Number: A204087)

    6 of 21  
    Drug NameBENZACLIN
    Active IngredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    CompanyVALEANT BERMUDA (Application Number: N050756)

    7 of 21  
    Drug NameACANYA
    Active IngredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    CompanyDOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208)

    8 of 21  
    Drug NameCLEOCIN PHOSPHATE
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPHARMACIA AND UPJOHN (Application Number: A062803); PHARMACIA AND UPJOHN (Application Number: N050441)

    9 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyABRAXIS PHARM (Application Number: N050635)

    10 of 21  
    Drug NameCLINDESSE
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPERRIGO PHARMA INTL (Application Number: N050793. Patents: 6899890, 9789057)

    11 of 21  
    Drug NameONEXTON
    Active IngredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    CompanyDOW PHARM (Application Number: N050819. Patents: 8288434, 8663699, 8895070, 9078870, 9504704, 9561208)

    12 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE AND TRETINOIN
    Active IngredientCLINDAMYCIN PHOSPHATE; TRETINOIN
    CompanyACTAVIS MID ATLANTIC (Application Number: A202564)

    13 of 21  
    Drug NameZIANA
    Active IngredientCLINDAMYCIN PHOSPHATE; TRETINOIN
    CompanyMEDICIS (Application Number: N050802. Patent: 6387383)

    14 of 21  
    Drug NameEVOCLIN
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyMYLAN PHARMS INC (Application Number: N050801. Patents: 7141237, 7374747)

    15 of 21  
    Drug NameCLINDETS
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPERRIGO CO (Application Number: A064136)

    16 of 21  
    Drug NameDUAC
    Active IngredientBENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    CompanySTIEFEL (Application Number: N050741)

    17 of 21  
    Drug NameVELTIN
    Active IngredientCLINDAMYCIN PHOSPHATE; TRETINOIN
    CompanyAQUA PHARMS LLC (Application Number: N050803)

    18 of 21  
    Drug NameCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPHARMACIA AND UPJOHN (Application Number: N050639)

    19 of 21  
    Drug NameCLEOCIN T
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyPHARMACIA AND UPJOHN (Application Number: N050537); PHARMACIA AND UPJOHN (Application Number: N050600); PHARMACIA AND UPJOHN (Application Number: N050615)

    20 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyAKORN INC (Application Number: A203048); BAXTER HLTHCARE CORP (Application Number: A208084); SANDOZ INC (Application Number: A201692)

    21 of 21  
    Drug NameCLINDAMYCIN PHOSPHATE
    Active IngredientCLINDAMYCIN PHOSPHATE
    CompanyAKORN (Application Number: A065513); ALVOGEN INC (Application Number: A062800); ALVOGEN INC (Application Number: A062801); ALVOGEN INC (Application Number: A062943); FOUGERA PHARMS INC (Application Number: A064159); FOUGERA PHARMS (Application Number: A064160); FOUGERA PHARMS (Application Number: A065067); FOUGERA PHARMS (Application Number: A065139); FOUGERA PHARMS (Application Number: A065254); FRESENIUS KABI USA (Application Number: A065346); FRESENIUS KABI USA (Application Number: A065347); G AND W LABS INC (Application Number: A062811); GLASSHOUSE PHARMS (Application Number: A209846); MYLAN LABS LTD (Application Number: A204748); MYLAN LABS LTD (Application Number: A204749); PERRIGO NEW YORK (Application Number: A064050); PERRIGO NEW YORK (Application Number: A065049); PERRIGO UK FINCO (Application Number: A090785); SAGENT PHARMS (Application Number: A090108); SAGENT PHARMS (Application Number: A090109); TARO PHARM INDS (Application Number: A065184); TELIGENT PHARMA INC (Application Number: A206945); VINTAGE PHARMS (Application Number: A203343); WEST-WARD PHARMS INT (Application Number: A062889); WEST-WARD PHARMS INT (Application Number: A065206); WOCKHARDT (Application Number: A063304)